Company intelligence / Profile preview
Reven Pharmaceuticals
Westminster / Golden*, Colorado, United Statesreven.com ↗
- Ownership
- Private
- Employees
- ~13
- Development stage
- Phase 2
01
Overview
Reven Pharmaceuticals develops proprietary pharmacological solutions targeting immune system homeostasis. Its lead asset, Rejuveinix (RJX), an intravenous formulation with antioxidant and anti-inflammatory properties, has completed early-phase clinical trials in sepsis and COVID-related acute lung/liver injury. The company reports successful completion of part one of a Phase II trial in high-risk COVID patients and continues to advance RJX across several indications including cardiovascular disease and oncology. Additional programs are at preclinical or IND-enabling stages targeting wound healing, CNS disorders, autoimmune diseases, ocular conditions, and more.
- Therapeutic areas
- OncologyCardiovascularInfectious Diseases
- Modalities
- Small moleculesProprietary antioxidant/anti-inflammatory formulations
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
03
Partnerships
No major pharma partnerships disclosed.
Beyond the preview
Go deeper on Reven Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Reven Pharmaceuticals.